ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy.

Abdulrahman M Alokda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.